Esteban Kloosterman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Esteban Kloosterman has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Jonathan Rosman
Cardiac Arrhythmia Service, Boca Raton, FL, USA
4 shared publicationsMurray Rosenbaum
Cardiac Arrhythmia Service, Boca Raton, FL, USA
4 shared publicationsEric Berkowitz
Cardiac Arrhythmia Service, Boca Raton, FL, USA
2 shared publicationsZachary Wettenstein
Florida Atlantic University, Boca Raton, FL, USA
2 shared publicationsBrian LA Starza
1 shared publicationJamil Wilcox
1 shared publication
Latest Publications
- 29 February 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (4) , 762-764
Widening the scope of complex cardiac implantable electronic devices implant considerations: Time for an integrated multidisciplinary approach
- 29 February 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (4) , 762-764
Widening the scope of complex cardiac implantable electronic devices implant considerations: Time for an integrated multidisciplinary approach
- 1 February 2023
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 14 (2) , 5348-5354
Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
- 1 February 2023
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 14 (2) , 5348-5354
Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
- Open Access
- 1 December 2021
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 12 (12) , 4812-4817
Treatment of Cryptogenic Stroke Patients with Atrial Fibrillation Detected by Insertable Cardiac Monitors Reduces Recurrent Stroke Risk to Background Levels
Atrial fibrillation (AF) is a known risk factor of ischemic stroke with a reported fivefold increase in incidence. However, it is not well established whether treatment with oral anticoagulation (OAC) in cryptogenic stroke patients with AF, detected by insertable cardiac monitors (ICMs), reduces the risk of recurrent stroke. We aimed to compare recurrent stroke rates between cryptogenic stroke patients who have AF detected by ICMs and thus started on OAC treatment and those without detected AF. We performed a combined retrospective and prospective analysis of consecutive patients who received an ICM indicated for cryptogenic stroke and were followed up with between July 2015 and November 2019. Patients with a prior documented history of AF were excluded. All patients were required to have a home remote monitoring system. We calculated the rates of AF detection and OAC initiation, then compared recurrent annualized stroke rates (ASRs) between patients with and without AF detected. A total of 298 patients with ICMs were included in the study [mean ± standard deviation age: 77 ± 11.7 years; female/male: 147/151; virtual CHA2DS2-VASc score: 4.96 ± 1.28 points]. AF was discovered in 91 patients (~30%) over a mean 19.3 months follow-up. Of those, 65 (71.4%) were started on OAC, 12 (13.2%) were already on OAC, and 10 (11%) remained non-anticoagulated. In four (4.4%) patients, OAC was started after recurrent stroke when AF was diagnosed. A total of 24 of 298 patients developed recurrent strokes (ASR: 5.0%). Among the 24 patients with recurrent strokes, four had new AF and were on OAC (ASR: 3.23%), six had new AF and were not anticoagulated (ASR: 26.62%), and 14 had no AF detected and no OAC (ASR: 4.20%). Our study found new AF detected by ICMs in almost one-third (30%) of cryptogenic stroke patients (consistent with previous studies), and the majority of them (89%) received OACs. There was no significant difference in the recurrent stroke rate among patients without AF detected and those with AF detected and on OAC. Rigorous arrhythmia monitoring using ICMs can increase new AF detection rates in cryptogenic stroke patients, thereby allowing early initiation of OACs, ultimately reducing the risk of recurrent stroke to background levels.
- 1 December 2021
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 12 (12) , 4812-4817
Open AccessTreatment of Cryptogenic Stroke Patients with Atrial Fibrillation Detected by Insertable Cardiac Monitors Reduces Recurrent Stroke Risk to Background Levels
Atrial fibrillation (AF) is a known risk factor of ischemic stroke with a reported fivefold increase in incidence. However, it is not well established whether treatment with oral anticoagulation (OAC) in cryptogenic stroke patients with AF, detected by insertable cardiac monitors (ICMs), reduces the risk of recurrent stroke. We aimed to compare recurrent stroke rates between cryptogenic stroke patients who have AF detected by ICMs and thus started on OAC treatment and those without detected AF. We performed a combined retrospective and prospective analysis of consecutive patients who received an ICM indicated for cryptogenic stroke and were followed up with between July 2015 and November 2019. Patients with a prior documented history of AF were excluded. All patients were required to have a home remote monitoring system. We calculated the rates of AF detection and OAC initiation, then compared recurrent annualized stroke rates (ASRs) between patients with and without AF detected. A total of 298 patients with ICMs were included in the study [mean ± standard deviation age: 77 ± 11.7 years; female/male: 147/151; virtual CHA2DS2-VASc score: 4.96 ± 1.28 points]. AF was discovered in 91 patients (~30%) over a mean 19.3 months follow-up. Of those, 65 (71.4%) were started on OAC, 12 (13.2%) were already on OAC, and 10 (11%) remained non-anticoagulated. In four (4.4%) patients, OAC was started after recurrent stroke when AF was diagnosed. A total of 24 of 298 patients developed recurrent strokes (ASR: 5.0%). Among the 24 patients with recurrent strokes, four had new AF and were on OAC (ASR: 3.23%), six had new AF and were not anticoagulated (ASR: 26.62%), and 14 had no AF detected and no OAC (ASR: 4.20%). Our study found new AF detected by ICMs in almost one-third (30%) of cryptogenic stroke patients (consistent with previous studies), and the majority of them (89%) received OACs. There was no significant difference in the recurrent stroke rate among patients without AF detected and those with AF detected and on OAC. Rigorous arrhythmia monitoring using ICMs can increase new AF detection rates in cryptogenic stroke patients, thereby allowing early initiation of OACs, ultimately reducing the risk of recurrent stroke to background levels.
- 3 April 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (5) , 1516
Misleading title and communication
- 3 April 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (5) , 1516
Misleading title and communication
- Open Access
- 18 December 2020
- Published by Wiley
Misleading Title and Communication Regarding Brief Communication entitled: First clinical use of real-time remote programming in cardiac implantable electronic devices. Dr. Toshimasa Okabe et al. J Cardiovascular Electrophysiol. 2020;31:2759-2761. DOI:10.1111/jce.14698
Title: Misleading Title and Communication.Regarding Brief Communication: First clinical use of real-time remote programming in cardiac implantable electronic devices. Dr. Toshimasa Okabe et al. J Cardiovascular Electrophysiol. 2020;31:2759-2761. DOI:10.1111/jce.14698Author: Dr. Esteban Martin Kloosterman
- 18 December 2020
- Published by Wiley
Open AccessMisleading Title and Communication Regarding Brief Communication entitled: First clinical use of real-time remote programming in cardiac implantable electronic devices. Dr. Toshimasa Okabe et al. J Cardiovascular Electrophysiol. 2020;31:2759-2761. DOI:10.1111/jce.14698
Title: Misleading Title and Communication.Regarding Brief Communication: First clinical use of real-time remote programming in cardiac implantable electronic devices. Dr. Toshimasa Okabe et al. J Cardiovascular Electrophysiol. 2020;31:2759-2761. DOI:10.1111/jce.14698Author: Dr. Esteban Martin Kloosterman
- Open Access
- 1 April 2019
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 10 (4) , 3593-3599
The Axillary Fossa: An Uncovered Hidden Site as a New Alternative for Cardiac Pacemaker and Defibrillator Implantation
Inadequate thickness of subcutaneous tissue, pectoralis muscle wasting, and/or a lack of availability of subpectoral space can become significant issues in patients with or requiring cardiovascular implantable electronic devices (CIEDs). This is particularly concerning but not exclusive in the elderly population, who may experience discomfort and hypersensitivity of the site as well as the potential for erosion and an increased risk of infection. Thus, the use of an alternative location, the axillary fossa, offers several advantages that make it a suitable option. Specifically, it usually has a preserved fat pad (even in thin patients); is unperturbed by arm movement; is not directly exposed to contact; is easily accessed with no significant compromise of neurovascular structures; and is near the conventional subclavicular sites, with enough lead length to reach in case of the need for generator replacement. Here, we present a series of five patients, including details of their anatomy and the implant techniques used. Two underwent device replacements, with one of them presenting with significant ongoing site discomfort and the other with extreme tissue thinning, respectively. Two patients with no significant fat layer or pectoral muscle wasting had new pacemakers implanted. Lastly, a biventricular implantable cardioverter-defibrillator generator was reimplanted in a younger patient who had issues with protrusion and discomfort in the setting of thin subcutaneous tissue and the subpectoral space being occupied by a large breast implant. In conclusion, the use of the axillary fossa as a new alternative CIED implantation site, using the proposed implant technique, appears feasible and safe and demonstrated excellent results related to patient comfort and adequate device cover in five cases.
- 1 April 2019
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 10 (4) , 3593-3599
Open AccessThe Axillary Fossa: An Uncovered Hidden Site as a New Alternative for Cardiac Pacemaker and Defibrillator Implantation
Inadequate thickness of subcutaneous tissue, pectoralis muscle wasting, and/or a lack of availability of subpectoral space can become significant issues in patients with or requiring cardiovascular implantable electronic devices (CIEDs). This is particularly concerning but not exclusive in the elderly population, who may experience discomfort and hypersensitivity of the site as well as the potential for erosion and an increased risk of infection. Thus, the use of an alternative location, the axillary fossa, offers several advantages that make it a suitable option. Specifically, it usually has a preserved fat pad (even in thin patients); is unperturbed by arm movement; is not directly exposed to contact; is easily accessed with no significant compromise of neurovascular structures; and is near the conventional subclavicular sites, with enough lead length to reach in case of the need for generator replacement. Here, we present a series of five patients, including details of their anatomy and the implant techniques used. Two underwent device replacements, with one of them presenting with significant ongoing site discomfort and the other with extreme tissue thinning, respectively. Two patients with no significant fat layer or pectoral muscle wasting had new pacemakers implanted. Lastly, a biventricular implantable cardioverter-defibrillator generator was reimplanted in a younger patient who had issues with protrusion and discomfort in the setting of thin subcutaneous tissue and the subpectoral space being occupied by a large breast implant. In conclusion, the use of the axillary fossa as a new alternative CIED implantation site, using the proposed implant technique, appears feasible and safe and demonstrated excellent results related to patient comfort and adequate device cover in five cases.
- Open Access
- 1 January 2019
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 10 (1) , 3477-3484
Remote Control of Cardiac Implantable Electronic Devices: Exploring the New Frontier—First Clinical Application of Real-time Remote-control Management of Cardiac Devices Before and After Magnetic Resonance Imaging
The purpose of the present study was to evaluate the performance of remote-control (RC) management of cardiac implantable electronic devices (CIEDs) in clinical practice using a new service model in patients undergoing magnetic resonance imaging (MRI) scans. The number of CIEDs is constantly growing, alongside the demands for prompt checks. Although remote CIED interrogation exists, ultimately, real-time remote management is the goal. In this study, patients with MRI-conditional devices suitable for RC interaction who required an MRI were enrolled. An onsite technician began the RC session by contacting the remote operator, applying the programmer wand, and keying in an access code. The device was remotely checked via encrypted Wi-Fi by an electrophysiologist using a laptop. An MRI-safe mode was programmed per a preestablished proprietary algorithm. Following the scan, patient devices were remotely reinterrogated and reprogrammed to baseline, with adjustments made as clinically necessary. Patients subsequently were asked to complete a survey. Ultimately, a total of 100 RC CIED reprogrammings were performed in 50 MRI sessions, prescan and postscan. The average RC time interaction was four minutes prescan and three minutes postscan, respectively. No complications occurred. Five patients had more than one MRI in this study and 15 patients had had previous MRIs. In eight patients, baseline settings were reprogrammed. Most patients (82%) were very satisfied, preferring device specialist remote management. Only 14 (32%) patients used home remote monitoring. In conclusion, RC management of CIEDs in the MRI setting is feasible, safe, and clinically relevant. Use of the MRI mode determination algorithm was safe, consistent, and efficient. Expanding RC in CIED management for service anytime, anywhere is the next challenge.
- 1 January 2019
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 10 (1) , 3477-3484
Open AccessRemote Control of Cardiac Implantable Electronic Devices: Exploring the New Frontier—First Clinical Application of Real-time Remote-control Management of Cardiac Devices Before and After Magnetic Resonance Imaging
The purpose of the present study was to evaluate the performance of remote-control (RC) management of cardiac implantable electronic devices (CIEDs) in clinical practice using a new service model in patients undergoing magnetic resonance imaging (MRI) scans. The number of CIEDs is constantly growing, alongside the demands for prompt checks. Although remote CIED interrogation exists, ultimately, real-time remote management is the goal. In this study, patients with MRI-conditional devices suitable for RC interaction who required an MRI were enrolled. An onsite technician began the RC session by contacting the remote operator, applying the programmer wand, and keying in an access code. The device was remotely checked via encrypted Wi-Fi by an electrophysiologist using a laptop. An MRI-safe mode was programmed per a preestablished proprietary algorithm. Following the scan, patient devices were remotely reinterrogated and reprogrammed to baseline, with adjustments made as clinically necessary. Patients subsequently were asked to complete a survey. Ultimately, a total of 100 RC CIED reprogrammings were performed in 50 MRI sessions, prescan and postscan. The average RC time interaction was four minutes prescan and three minutes postscan, respectively. No complications occurred. Five patients had more than one MRI in this study and 15 patients had had previous MRIs. In eight patients, baseline settings were reprogrammed. Most patients (82%) were very satisfied, preferring device specialist remote management. Only 14 (32%) patients used home remote monitoring. In conclusion, RC management of CIEDs in the MRI setting is feasible, safe, and clinically relevant. Use of the MRI mode determination algorithm was safe, consistent, and efficient. Expanding RC in CIED management for service anytime, anywhere is the next challenge.
- 31 January 2016
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 7 (1) , 2249-2256
Novel Cardiac Device Management System Using Remote Online and Real-time Interrogation with Guided Reprogramming at the Cardiologist’s Office
Innovations in Cardiac Rhythm Management
- 31 January 2016
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 7 (1) , 2249-2256
Novel Cardiac Device Management System Using Remote Online and Real-time Interrogation with Guided Reprogramming at the Cardiologist’s Office
Innovations in Cardiac Rhythm Management
- Open Access
- Vol. 17 (3) , 6663-6667
A Novel Low Right Atrial–approach Transseptal Puncture Technique for Large-bore Deflectable Sheaths: Enhancing Control, Precision, and Safety
The conventional transseptal puncture (TSP) technique, developed in the 1960s, remains a procedural standard but offers limited control when applied to contemporary large-bore deflectable sheaths. The objective of this study is to describe a novel low right atrial (RA)–approach TSP technique designed to optimize control, precision, and safety when using large-bore deflectable systems. This technique eliminates the need for superior vena cava (SVC) positioning and instead advances the deflectable sheath–dilator assembly from the low RA toward the interatrial septum under imaging guidance. The deflectable capabilities of the sheath, protected by the spiral or J-tip wire, enable atraumatic manipulation and precise targeting before puncture. This method was used in 63 consecutive procedures, including pulsed field ablation, left atrial appendage occlusion, and concomitant cases. All punctures were completed successfully without complications. The average time from inferior vena cava advancement to septal crossing was 2–3 min. This new low RA–approach TSP technique provides superior sheath control and maneuvering of large-bore deflectable systems, offering competitive safety and efficiency as an excellent alternative to conventional SVC-based approaches.
- Vol. 17 (3) , 6663-6667
Open AccessA Novel Low Right Atrial–approach Transseptal Puncture Technique for Large-bore Deflectable Sheaths: Enhancing Control, Precision, and Safety
The conventional transseptal puncture (TSP) technique, developed in the 1960s, remains a procedural standard but offers limited control when applied to contemporary large-bore deflectable sheaths. The objective of this study is to describe a novel low right atrial (RA)–approach TSP technique designed to optimize control, precision, and safety when using large-bore deflectable systems. This technique eliminates the need for superior vena cava (SVC) positioning and instead advances the deflectable sheath–dilator assembly from the low RA toward the interatrial septum under imaging guidance. The deflectable capabilities of the sheath, protected by the spiral or J-tip wire, enable atraumatic manipulation and precise targeting before puncture. This method was used in 63 consecutive procedures, including pulsed field ablation, left atrial appendage occlusion, and concomitant cases. All punctures were completed successfully without complications. The average time from inferior vena cava advancement to septal crossing was 2–3 min. This new low RA–approach TSP technique provides superior sheath control and maneuvering of large-bore deflectable systems, offering competitive safety and efficiency as an excellent alternative to conventional SVC-based approaches.